Omicron
- News
New Covid variant ‘FLiRT’ capable of evading the immune system: Experts
New Delhi: The new Covid-19 variant ‘FLiRT’, which is spreading fast in the US, is capable of evading the immune system due to a trans substitution of amino acids between two spike…
- India
India reports 602 new Covid cases, 511 of JN.1 series variant
New Delhi: India has recorded 602 new Covid-19 infections in the past 24 hours, pushing the the total number of active cases to 4,440 on Wednesday. The country had recorded 865 new…
- Health
Kids with COVID remain infectious for average 3 days: Indian-origin scientists
New York: Children infected with the Omicron variant remained infectious for a median time of three days after testing positive for the virus, Indian-origin scientists have found. School policies that require students…
- World
2 new studies suggest BA.2.86 less immune-evasive than feared
New York: Amid fresh concerns of Covid-19 due to the new highly mutant Omicron sub variant BA.2.86, two new studies from the US have confirmed that it is less contagious as well…
- Health
After EG.5, WHO flags another Covid variant BA.2.86
New Delhi: After EG.5 raised concerns for a new Covid outbreak, the World Health Organization (WHO) has now flagged another sub-variant of Omicron BA.2.86, dubbed as BA.X. BA.2.86 is from Omicron’s BA.…
- Middle East
Kuwait detects first case of new EG.5 COVID variant
Kuwait: The Kuwait’s Ministry of Health announced on Tuesday that it detected the first case of EG.5, a new COVID variant, the Kuwait News Agency (KUNA) reported. The ministry noted that the…
- World
New COVID variant EG.5.1 spreading quickly in UK: Report
London: A new COVID variant which has descended from the rapidly spreading Omicron and was first flagged in the UK last month is now said to be spreading quickly in the country,…
- India
Omicron-specific mRNA-based booster vaccine launched
New Delhi: Union minister Jitendra Singh on Saturday launched an Omicron-specific mRNA-based booster vaccine for Covid. GEMCOVAC-OM is India’s first mRNA vaccine developed using the indigenous platform technology by Gennova, with funding…
- India
Drug controller’s nod for Omicron-specific mRNA-based vaccine
New Delhi: India’s drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova Biopharmaceuticals under Mission Covid Suraksha, the Department of Biotechnology said on Tuesday. The Department…
- World
New Omicron subvariant continues to spread rapidly in US
Los Angeles: New Omicron subvariant XBB.1.16 continues to spread rapidly in the US, with its prevalence increasing to 12.5 per cent this week, according to the latest data updated by the US…
- World
New Omicron subvariant spreading in US
Los Angeles: A new Omicron subvariant is spreading in the United States, and has accounted for nearly 10 per cent of new weekly Covid-19 cases reported across the country, according to data…
- India
TN man who died of Covid was infected with Omicron XBB variant
Chennai: A 27-year-old man who had died of Covid-19 in a private hospital in Tamil Nadu’s Tiruchi was infected with the Omicron-XBB variant, officials said on Tuesday. The whole genome sequencing report…
- World
Omicron XBB.1.5 variant is highly transmissible and infectious: Lancet
Tokyo: The XBB.1.5 — subvariant of SARS-CoV-2 Omicron — has high transmissibility and infectivity, according to a study published in the journal Lancet Infectious Diseases. Researchers at the University of Tokyo in…
- World
Omicron subvariant XBB.1.5 accounts for nearly 90% new Covid cases in US
Washington: The highly transmissible Omicron subvariant XBB.1.5 now accounts for nearly 90 per cent of all Covid-19 cases reported in the US, according to the latest estimates by the Centers for Disease…
- World
Omicron subvariant XBB.1.5 prevalence jumps to 75 pc in US
Los Angeles: The highly transmissible Omicron subvariant XBB.1.5 now accounts for about three-fourths of all Covid-19 cases reported in the US this week, according to the estimates released by the US Centers…
